France begins clinical trials of remedies 4 drugs including Ebola hemorrhagic fever March 24 6:34
The French National Agency for Health and Medical Research has announced that it has launched four clinical trials to treat patients with the new coronavirus, including antivirals, which are being developed for the treatment of Ebola hemorrhagic fever.
Regarding the treatment of the new coronavirus, attempts have been made in various countries to administer anti-HIV drugs to suppress the onset of AIDS and to administer drugs for influenza, but so far the effect has been confirmed with certainty There is no cure.
Against this background, the French National Institute of Health and Medicine announced on April 22 that it has started four types of clinical trials using antiviral drugs to treat patients.
In particular,
レ Remdecivir, an antiviral drug under development as a treatment for Ebola hemorrhagic fever,
薬 Combination of lopinavir and ritonavir to suppress the development of AIDS,
も の The combination of these drugs with "interferon beta"
ク ロ ロ A total of four types of "chloroquine" used for the treatment of malaria.
The study will provide medication to 3,200 patients hospitalized in six European countries, including France, the United Kingdom, Spain, and the Netherlands, and will provide the collected data to the World Health Organization (WHO).
The National Institute of Health and Medical Research said on a telephone press conference on the 23rd that `` after 15 days the initial analysis results on the effectiveness of treatment will be found '', and hopes that it will lead to the establishment of an effective treatment method It has been.